Ethical Considerations in Screening for Rapid Eye Movement Sleep Behavior Disorder in the General Population

Clinical studies have shown that up to 90% of patients with idiopathic rapid eye movement sleep behavior disorder (RBD) will eventually be diagnosed with a clinical α‐synucleinopathy. Because of this high conversion rate, screening for RBD is often performed to identify eligible participants for studies aimed at elucidating the prodromal phase of α‐synucleinopathies. However, screening for RBD, especially in the general population, raises many ethical dilemmas. In light of the existing ethical literature and our experience in establishing a screening approach for RBD in the Rotterdam Study, we discuss ethical dilemmas when screening for RBD in population‐based studies. We conclude that informing study participants about the reason for invitation and the possible trajectory that lies ahead when participating is essential. However, participants should not be troubled unnecessarily by giving them detailed information about possible diagnoses or associated disease risks. © 2020 International Parkinson and Movement Disorder Society

[1]  D. Kunz,et al.  Clinical trials in REM sleep behavioural disorder: challenges and opportunities , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  Y. Liu,et al.  Probable REM sleep behavior disorder and risk of stroke , 2017, Neurology.

[3]  F. Sixel-Döring.  Prognostic Counseling for Patients With Idiopathic/Isolated Rapid Eye Movement Sleep Behavior Disorder: Should We Tell Them What's Coming? No , 2019, Movement disorders clinical practice.

[4]  J. Santamaria,et al.  Idiopathic REM sleep behavior disorder in the elderly Spanish community: a primary care center study with a two-stage design using video-polysomnography. , 2017, Sleep medicine.

[5]  Brenda C T Kieboom,et al.  Objectives, design and main findings until 2020 from the Rotterdam Study , 2020, European Journal of Epidemiology.

[6]  Yves Dauvilliers,et al.  REM sleep behaviour disorder , 2018, Nature Reviews Disease Primers.

[7]  J. Molinuevo,et al.  Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients , 2014, PloS one.

[8]  B. Knoppers,et al.  Return of individual genomic research results: are laws and policies keeping step? , 2019, European Journal of Human Genetics.

[9]  J M Wardlaw,et al.  Acting on incidental findings in research imaging , 2015, BMJ : British Medical Journal.

[10]  C. Wade.  What Is the Psychosocial Impact of Providing Genetic and Genomic Health Information to Individuals? An Overview of Systematic Reviews. , 2019, The Hastings Center report.

[11]  Carlos H Schenck,et al.  Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. , 2013, Sleep medicine.

[12]  Huidong Tang,et al.  A community-based study of risk factors for probable rapid eye movement sleep behavior disorder. , 2017, Sleep medicine.

[13]  R. Postuma,et al.  Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? , 2017, Sleep medicine reviews.

[14]  C. Brayne,et al.  Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease Research. , 2017, The journal of prevention of Alzheimer's disease.

[15]  V. Pankratz,et al.  Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population‐based study , 2012, Annals of neurology.

[16]  Ethical framework for the detection, management and communication of incidental findings in imaging studies, building on an interview study of researchers’ practices and perspectives , 2017, BMC medical ethics.

[17]  D. Berg,et al.  Patients' views on the ethical challenges of early Parkinson disease detection , 2020, Neurology.

[18]  Jane S. Paulsen,et al.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases , 2013, Progress in Neurobiology.

[19]  Margarete Delazer,et al.  Validation of the Innsbruck REM sleep behavior disorder inventory , 2012, Movement disorders : official journal of the Movement Disorder Society.

[20]  N. Zhang,et al.  Prevalence of REM sleep behavior disorder in Sun City, Arizona , 2020, Heliyon.

[21]  Shuohua Chen,et al.  Risk factors for probable REM sleep behavior disorder , 2016, Neurology.

[22]  T. Kim,et al.  REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. , 2013, Sleep.

[23]  G. Greenough,et al.  Ethical considerations in REM sleep behavior disorder. , 2013, Continuum.

[24]  Evžen Růžička,et al.  Screening for REM sleep behavior disorder in the general population. , 2016, Sleep medicine.

[25]  K. Nakashima,et al.  Validity of the Japanese version of the REM Sleep Behavior Disorder (RBD) Screening Questionnaire for detecting probable RBD in the general population , 2015, Psychiatry and clinical neurosciences.

[26]  B. Boeve,et al.  Physician and patient determinants of prognostic counseling in idiopathic REM sleep-behavior disorder. , 2019, Sleep medicine.

[27]  Klaus Seppi,et al.  Probable RBD and association with neurodegenerative disease markers: A population‐based study , 2015, Movement disorders : official journal of the Movement Disorder Society.

[28]  Birgit Frauscher,et al.  Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population , 2018, Sleep.

[29]  Poul Jennum,et al.  A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study , 2012, Movement disorders : official journal of the Movement Disorder Society.

[30]  W. Oertel,et al.  Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[31]  Ambra Stefani,et al.  Idiopathic REM sleep behaviour disorder and neurodegeneration — an update , 2018, Nature Reviews Neurology.

[32]  Yves Dauvilliers,et al.  Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study , 2019, Brain : a journal of neurology.

[33]  W. Oertel,et al.  Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study , 2015, Annals of neurology.

[34]  Laura Verga,et al.  The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. , 2019, Sleep medicine reviews.

[35]  E. S. St. Louis.  Prognostic Counseling for Patients With Idiopathic/Isolated REM Sleep Behavior Disorder: Should We Tell Them What's Coming? Yes , 2019, Movement disorders clinical practice.

[36]  R. Postuma,et al.  Screening for prodromal Parkinson's disease in the general community: a sleep-based approach. , 2016, Sleep medicine.

[37]  Joan Santamaria,et al.  Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions , 2016, The Lancet Neurology.

[38]  Y. Inoue,et al.  Prevalence and clinical characteristics of REM sleep behavior disorder in Japanese elderly people. , 2020, Sleep.

[39]  G. Pravettoni,et al.  A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases , 2018, Front. Genet..